These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 6144867)

  • 1. A genetic marker for atherosclerosis?
    Mandrup-Poulsen T; Owerbach D; Mortensen SA; Johansen K; Meinertz H; Sørensen H; Nerup J
    Lancet; 1984 May; 1(8386):1131. PubMed ID: 6144867
    [No Abstract]   [Full Text] [Related]  

  • 2. A genetic marker for atherosclerosis?
    Hansen ES
    Lancet; 1984 Apr; 1(8382):911. PubMed ID: 6143218
    [No Abstract]   [Full Text] [Related]  

  • 3. [Polymorphism of the DNA restriction fragment length flanking the insulin gene. A genetic marker for diabetic mellitus or atherosclerosis?].
    Mandrup-Poulsen T; Owerbach D; Johansen K; Nerup J
    Ugeskr Laeger; 1985 Jun; 147(26):2065-71. PubMed ID: 2996193
    [No Abstract]   [Full Text] [Related]  

  • 4. DNA sequences flanking the insulin gene on chromosome 11 confer risk of atherosclerosis.
    Mandrup-Poulsen T; Owerbach D; Mortensen SA; Johansen K; Meinertz H; Sørensen H; Nerup J
    Lancet; 1984 Feb; 1(8371):250-2. PubMed ID: 6142996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between DNA-sequences flanking the insulin-gene and atherosclerosis.
    Nerup J; Mandrup-Poulsen T; Owerbach D; Johansen K; Ingerslev J; Hansen AT
    Acta Endocrinol Suppl (Copenh); 1985; 272():35-41. PubMed ID: 3914802
    [No Abstract]   [Full Text] [Related]  

  • 6. [Chlorpropamide-alcohol test as a marker of vascular complications of non-insulin-dependent diabetes mellitus].
    Balabolkin MI; Levitskaia ZI; Sherashova EIa
    Ter Arkh; 1984; 56(12):128-30. PubMed ID: 6395431
    [No Abstract]   [Full Text] [Related]  

  • 7. Genetic polymorphisms and atherosclerosis.
    Galton DJ
    Monogr Atheroscler; 1986; 14():113-8. PubMed ID: 3090427
    [No Abstract]   [Full Text] [Related]  

  • 8. DNA polymorphisms flanking insulin gene and atherosclerosis.
    Jowett NI; Rees A; Caplin J; Williams LG; Galton DJ
    Lancet; 1984 Aug; 2(8398):348. PubMed ID: 6146887
    [No Abstract]   [Full Text] [Related]  

  • 9. Possible association between DNA sequences flanking the insulin gene and atherosclerosis.
    Owerbach D; Johansen K; Billesbølle P; Poulsen S; Schroll M; Nerup J
    Lancet; 1982 Dec; 2(8311):1291-3. PubMed ID: 6128593
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipoprotein (a): genetic marker for atherosclerosis?
    Breckenridge WC
    CMAJ; 1990 Jul; 143(2):115. PubMed ID: 2364334
    [No Abstract]   [Full Text] [Related]  

  • 11. [Case of familial hypoalphalipoproteinemia, type 2 diabetes mellitus and markedly advanced atherosclerosis with ABCAlexon 4 minus transcript in macrophages].
    Saito M; Eto M; Nisimatsu S; Kume Y; Kawasaki H; Yoneda M; Matsuda M; Matsuki M; Kaku K
    Nihon Naika Gakkai Zasshi; 2002 Sep; 91(9):2762-4. PubMed ID: 12373902
    [No Abstract]   [Full Text] [Related]  

  • 12. [Arteriosclerosis risk factors in the offspring and siblings of type 2 diabetics].
    Jirkovská A; Válek V; Skibová J; Poledne R; Petrásek R
    Vnitr Lek; 1991; 37(7-8):671-7. PubMed ID: 1755208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complement component 3 (C3) genetics and diabetes mellitus.
    Krantz S; Stelter F; Lober M; Gromoll B
    Biomed Biochim Acta; 1990; 49(12):1237-41. PubMed ID: 2097995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [HLA antigen markers in patients with atherosclerosis].
    Bertuch H; Pilger E; Lanzer G; Hönigl K; Stark G
    Vasa Suppl; 1988; 26():191-3. PubMed ID: 3201372
    [No Abstract]   [Full Text] [Related]  

  • 15. Quantitative trait locus mapping of genetic modifiers of metabolic syndrome and atherosclerosis in low-density lipoprotein receptor-deficient mice: identification of a locus for metabolic syndrome and increased atherosclerosis on chromosome 4.
    Seidelmann SB; De Luca C; Leibel RL; Breslow JL; Tall AR; Welch CL
    Arterioscler Thromb Vasc Biol; 2005 Jan; 25(1):204-10. PubMed ID: 15514201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. G protein polymorphisms in hypertension, atherosclerosis, and diabetes.
    Siffert W
    Annu Rev Med; 2005; 56():17-28. PubMed ID: 15660499
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mapping of microsatellite loci and association of aorta atherosclerosis with LG VI markers in the rabbit.
    Korstanje R; Gillissen GF; Kodde LP; Den Bieman M; Lankhorst A; Van Zutphen LF; Van Lith HA
    Physiol Genomics; 2001 Jun; 6(1):11-8. PubMed ID: 11395542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Epidemiology and molecular genetics of atherosclerosis].
    Cambien F; De Tand MF; Moreel JF
    Ann Cardiol Angeiol (Paris); 1991 May; 40(5):231-6. PubMed ID: 1859121
    [No Abstract]   [Full Text] [Related]  

  • 19. Divergent association of apolipoprotein E polymorphism with vascular disease in patients with NIDDM and control subjects.
    Vauhkonen I; Niskanen L; Ryynänen M; Voutilainen R; Partanen J; Töyry J; Mercuri M; Rauramaa R; Uusitupa M
    Diabet Med; 1997 Sep; 14(9):748-56. PubMed ID: 9300224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular markers for atherosclerosis.
    Ballantyne CM; Abe Y
    J Cardiovasc Risk; 1997; 4(5-6):353-6. PubMed ID: 9865666
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.